一项以人口为基础的注册研究,研究了芬兰的牛皮相关疾病负担
Liisa Ukkola-Vuoti1, Anton Klåvus1, Iiro Toppila1
1Medaffcon Oy, Espoo, Finland.
Frontiers in medicine
|August 6, 2025
概括
开始生物疗法显著降低了斑块性牛皮 (PSO) 患者的医疗费用和工作缺勤. 然而,药物切换显示了持续的未满足需求,表明需要在PSO管理中优化治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 药物经济学 药物经济学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 斑块性牛皮 (PSO) 治疗的进步仍然留下未满足的需求.
- 描述患者开始或切换生物药物治疗对于了解这些需求至关重要.
研究的目的:
- 描述PSO患者开始或切换生物治疗的特征.
- 评估生物治疗对医疗保健资源利用 (HCRU),病假和残疾养老金的影响.
主要方法:
- 利用芬兰 (2013-2021) 的电子医疗保健数据.
- 分析了购买生物药物的PSO成年患者,将他们分为首次使用生物药物的用户和转换者.
- 从第一个生物购买或转换到2022年,跟踪患者.
主要成果:
- 在PSO患者中首次启动生物治疗显著减少了医疗保健接触和住院时间,并降低了成本.
- 在首次生物启动后,工作缺席率下降,但对于转换者来说,缺席率仍然适度和线性.
- 与第一个生物队列相比,切换者在残疾养老金中的患者比例更高.
结论:
- 及时启动生物处理对于管理PSO至关重要.
- 仍然存在大量未满足的需求,特别是在切换生物药物的患者中.
- 进一步的研究应该评估早期,高效的治疗利用在PSO的好处.
相关概念视频
Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
Prevalence and Incidence
815
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
815
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Introduction to Epidemiology
1.0K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.0K
Bias in Epidemiological Studies
683
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
683
Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K


